Portola Pharmaceuticals
23 clinical trials · Sponsor
◉ Watch Portola Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) (NCT04021082) | Portola Pharmaceuticals | 2019-11-15 |
| BRAVO - Betrixaban Registry Using Real Time Observations in Acute Medical Illness to Assess Venous Thrombosis and Bleeding Outcomes (NCT03613402) | Portola Pharmaceuticals | 2018-09-01 |
| The Effect o f Hepatic Impairment on the Pharmacokinetics and Pharmacodynamics of Betrixiban, an Oral FXa Antagonist (NCT03397888) | Portola Pharmaceuticals | 2017-11-16 |
Track Portola Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.